Farrell Geraldine T

CIK 00016323851 companyBLACKROCK, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001632385

Recent Transactions

34 trades

Disposition to Issuer
Nexvet Biopharma plc
Restricted Share Units
2017-07-31$6.59/sh−30,000→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Option to Purchase Shares
2017-07-31−20,000→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−18,980→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−33,180→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-07-01−10,000→ 30,000 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+2,866→ 26,986 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-07-01−2,340→ 4,678 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2017-07-01−6,194→ 0 total
Disposition to Issuer
Nexvet Biopharma plc
Restricted Share Units
2017-07-01$6.59/sh−4,678→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Option to Purchase Shares
2017-07-01−2,866→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+10,000→ 16,640 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+2,340→ 18,980 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+6,194→ 33,180 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-09-05+40,000→ 40,000 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2016-07-01$0.13/sh+2,867→ 24,120 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2016-07-01$0.13/sh+2,340→ 6,640 total
Exercise/Conversion
Nexvet Biopharma plc
Options to Purchase Shares
2016-07-01−2,867→ 2,866 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2016-07-01−2,340→ 7,018 total
Sale
Nexvet Biopharma plc
Ordinary Shares
2016-03-03$3.27/sh−132→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Options to purchase shares
2015-11-23−4,300→ 5,733 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-11-23$0.13/sh+4,300→ 21,253 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-11-05$0.13/sh+6,195→ 16,953 total
Exercise/Conversion
Nexvet Biopharma plc
Options to purchase shares
2015-11-05−6,195→ 6,194 total
Award
Nexvet Biopharma plc
Restricted Share Units
2015-09-03+9,358→ 9,358 total
Exercise/Conversion
Nexvet Biopharma plc
Options to purchase shares
2015-07-01−2,867→ 10,033 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-07-01$0.13/sh+2,867→ 10,758 total
Award
Nexvet Biopharma plc
Ordinary Shares
2015-06-08$0.13/sh+4,300→ 4,300 total
Award
Nexvet Biopharma plc
Options to Purchase Shares
2015-05-18+20,000→ 20,000 total
Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-02-10+1,696→ 7,891 total
Conversion
Nexvet Biopharma plc
Series B Preference Shares
2015-02-10−1,696→ 0 total
Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-02-10+36→ 76 total
Conversion
Nexvet Biopharma plc
Series B Preference Shares
2015-02-10−56→ 0 total
Conversion
Nexvet Biopharma plc
Ordinary Shares
2015-02-10+56→ 132 total
Conversion
Nexvet Biopharma plc
Series A Investment Preference Shares
2015-02-10−36→ 0 total

Companies

Nexvet Biopharma plc
VP Operations, General Counsel

Recent Filings

Address

C/O NEXVET BIOPHARMA PLC NIBRT; FOSTERS AVENUE, MOUNT MERRION

BLACKROCK, L2

View on SEC.gov